Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.


TSXV:COV - Post by User

Bullboard Posts
Comment by TheMonolithon Oct 06, 2017 11:46am
116 Views
Post# 26786052

RE:RE:RE:RE:RE:RE:MediClear Pre-Op Will Be A Home Run

RE:RE:RE:RE:RE:RE:MediClear Pre-Op Will Be A Home RunYou may prove to be right, but I don't think you are giving much creedence to Brian's own comments.  He's proven enough out to listen and believe, until proven otherwise.  He's delivered on many things he stated, and he has been cautious on forward-looking statements on several fronts.  He clearly got excited late last year about something, and it now is showing that it had to be about the Pre-Op dressing.  If he's calling it a Home Run, then I believe he had sufficient reason behind saying that.  I think zen is correct that licensing is the route.  I think we'll see confirmation of this by spring of 2018.  Their coating product received a licensing deal right out of the gate, but Brian hasn't necessarily talked that product up. 

I'm fine with your skeptical nature, and just presenting the other side as someone who's followed the company now for a while.  
Bullboard Posts

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse